Answers are grounded in this paper and cite their sources.
The disclosure of APOE genotyping results to adult children of patients with Alzheimer's disease did not result in significant short-term psychological risks. Test-related distress was reduced among those who learned that they were APOE epsilon4-negative. Persons with high levels of emotional distress before undergoing genetic testing were more likely to have emotional difficulties after disclosure. (ClinicalTrials.gov number, NCT00571025.)
No takes yet. Share an insight, caveat, or question.
Green et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: